Health ❯ Healthcare ❯ Patient Outcomes

Treatment Efficacy

Side Effects Response Rates Adverse Effects Progression-Free Survival HbA1c Levels Clinical Study Results Hearing Improvement Ear Discharge Resolution Relapse Prevention Medication Timing Hair Regrowth Muscle Pain Reduction Quality of Life Improvements Long-term Clinical Outcomes Combination Therapy Overall Survival Pain Management Durability of Response Steroid Use Reduction Sight-Threatening Complications Recovery Improvement Seizure Management Satisfaction with Hair Coverage Survival Rates Cancer Recurrence Long-term Monitoring Cancer Remission

Erleada Plus Hormone Therapy Cuts Recurrence and Death in High‑Risk Localized Prostate Cancer

Late‑stage trial results signal possible expansion of the Johnson & Johnson drug into earlier‑stage care and now move to regulatory review.

New CAR-T Designs Deliver Low-Dose Remissions and Expose a Senescence Risk

Kodiak’s Zenkuda Hits Phase 3 Goal in Diabetic Retinopathy Prompting Faster FDA Filing

Trials Show Fecal Transplants Enhance Cancer Immunotherapy, Including Longer PFS in Randomized Kidney Study

Lilly Reports Zepbound Plus Taltz Beat Taltz Alone in Psoriatic Arthritis Trial

Swedish Study Ties Lower Ipilimumab Dose to Longer Survival and Less Toxicity in Advanced Melanoma

Veradermics Advances Long-Acting Oral Minoxidil Into Phase 3 U.S. Trials

FDA Approves Lurbinectedin Plus Atezolizumab for First-Line Maintenance in Extensive-Stage SCLC